PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15800929-9	2005	All of the 10-week samples treated with either BaP or BaP-UVA showed detectable mutations at codons 12 and 13, but the genetic load was significantly higher in BaP-UVA-treated mice than in those exposed only to BaP.	uva	58-61	prohibitin 2	Mus musculus	54-57	
15800929-9	2005	All of the 10-week samples treated with either BaP or BaP-UVA showed detectable mutations at codons 12 and 13, but the genetic load was significantly higher in BaP-UVA-treated mice than in those exposed only to BaP.	uva	58-61	prohibitin 2	Mus musculus	54-57	
15800929-9	2005	All of the 10-week samples treated with either BaP or BaP-UVA showed detectable mutations at codons 12 and 13, but the genetic load was significantly higher in BaP-UVA-treated mice than in those exposed only to BaP.	uva	58-61	prohibitin 2	Mus musculus	54-57	
15800929-9	2005	All of the 10-week samples treated with either BaP or BaP-UVA showed detectable mutations at codons 12 and 13, but the genetic load was significantly higher in BaP-UVA-treated mice than in those exposed only to BaP.	uva	164-167	prohibitin 2	Mus musculus	47-50	
15800929-9	2005	All of the 10-week samples treated with either BaP or BaP-UVA showed detectable mutations at codons 12 and 13, but the genetic load was significantly higher in BaP-UVA-treated mice than in those exposed only to BaP.	uva	164-167	prohibitin 2	Mus musculus	54-57	
15800929-9	2005	All of the 10-week samples treated with either BaP or BaP-UVA showed detectable mutations at codons 12 and 13, but the genetic load was significantly higher in BaP-UVA-treated mice than in those exposed only to BaP.	uva	164-167	prohibitin 2	Mus musculus	54-57	
15800929-9	2005	All of the 10-week samples treated with either BaP or BaP-UVA showed detectable mutations at codons 12 and 13, but the genetic load was significantly higher in BaP-UVA-treated mice than in those exposed only to BaP.	uva	164-167	prohibitin 2	Mus musculus	54-57